How do I take etanercept (Enbrel) to treat psoriasis?
ANSWER
You take etanercept (Enbrel) by injecting it under your skin at home. You use it twice weekly for 3 months. After that, you inject it once a week.
From: Biologic Medications for Psoriasis WebMD Medical Reference
Reviewed by Stephanie S. Gardner on July 17, 2019
SOURCES:
Abel, E. "Psoriasis," ACP Medicine, BC Decker, 2005.
American Academy of Dermatology.
Amgen Prescribing Information, Amjevita.
Bruce E. Strober, MD, PhD, associate professor, vice chairman, director of clinical trials, department of dermatology, University of Connecticut; consultant to Amgen, Biogen, Genentech, Fujisawa, NexGenix Pharmaceuticals Holdings Inc. and 3M.
Coxentyx.com.
FDA: "FDA approves new psoriasis drug Taltz," “FDA approves Amjevita, a biosimilar to Humira,” "Cosentyx Medication Guide," "FDA approves new psoriasis drug," "Taltz Medication Guide."
Jeffrey M. Weinberg, MD, Mount Sinai St. Luke's, New York; associate clinical professor of dermatology, Columbia University College of Physicians and Surgeons; consultant to Amgen and Genentech.
National Institute of Arthritis and Musculoskeletal and Skin Diseases.
National Psoriasis Foundation.
PubMed Health: “Certolizumab (Injection),” “Golimumab (Injection).”
SOURCES:
Abel, E. "Psoriasis," ACP Medicine, BC Decker, 2005.
American Academy of Dermatology.
Amgen Prescribing Information, Amjevita.
Bruce E. Strober, MD, PhD, associate professor, vice chairman, director of clinical trials, department of dermatology, University of Connecticut; consultant to Amgen, Biogen, Genentech, Fujisawa, NexGenix Pharmaceuticals Holdings Inc. and 3M.
Coxentyx.com.
FDA: "FDA approves new psoriasis drug Taltz," “FDA approves Amjevita, a biosimilar to Humira,” "Cosentyx Medication Guide," "FDA approves new psoriasis drug," "Taltz Medication Guide."
Jeffrey M. Weinberg, MD, Mount Sinai St. Luke's, New York; associate clinical professor of dermatology, Columbia University College of Physicians and Surgeons; consultant to Amgen and Genentech.
National Institute of Arthritis and Musculoskeletal and Skin Diseases.
National Psoriasis Foundation.
PubMed Health: “Certolizumab (Injection),” “Golimumab (Injection).”
THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.
This tool does not provide medical advice. See additional information.